Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a system-level update. No visible content or functionality changes are indicated in the provided changes.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays Revision: v3.6.4 in place of Revision: v3.6.3, indicating a minor platform update to the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page shows a revision update from v3.6.2 to v3.6.3, indicating a minor system or documentation update. There are no visible changes to the page content or its purpose implied by this update.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now shows an updated site revision, v3.6.2, replacing the previous v3.6.0. This reflects a small platform update rather than changes to the trial details or page structure.SummaryDifference0.0%

- Check79 days agoChange DetectedEnrollment status updated to 'No longer looking for participants', signaling recruitment closure. The update adds navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts labeling for Intervention/Treatment, with the site revision noted as v3.6.0.SummaryDifference0.3%

- Check86 days agoChange DetectedRevision metadata on the page was updated from v3.5.4 to v3.5.5, indicating a minor backend or template update rather than a content change.SummaryDifference0.0%

Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.